Peter Murray, Editor

About the Author Peter Murray, Editor


How Analysts View Netflix, Inc. (NFLX) Post 3Q:17 Results

In a research note released Tuesday, Aegis analyst Victor Anthony reiterated a Hold rating on …

Read more

Cantor Pounds the Table on Valeant Pharmaceuticals Intl Inc (VRX)

Fears about financial control should be a buying opportunity in Valeant stock, says Cantor.

Read more

Maxim Pounds the Table on MannKind Corporation (MNKD)

Will Mannkind file bankruptcy? Jason Kolbert says no.

Read more

Fixed: Canaccord Highlights Upcoming Catalysts For Palatin Technologies, Inc. (PTN) Bulls

John Newman continues to expect NDA in 2018 for bremelanotide, while pipeline moves forward.

Read more

Walt Disney Co’s (DIS) Soggy Outlook Tests Investors Patience; Credit Suisse Weighs in

Credit Suisse remains bullish on Walt Disney despite earnings warning.

Read more

The Medicines Company (MDCO): How Much Vabomere Worth?

This morning, The Medicines Company (NASDAQ:MDCO) reported that the FDA approved its urinary tract infection treatment Vabomere, …

Read more

The Medicines Company (MDCO): Inclisiran Shows Momentum on Longer-Term Data, Oppenheimer Weighs in

Yesterday, at the European Society of Cardiology (ESC) Congress 2017 in Barcelona, The Medicines Company …

Read more

Guess?, Inc. (GES) Q2: Bulls Win, What’s Next?

Guess?, Inc. Rallies on Investor Optimism Over Earnings Beat

Read more

Why Maxim Raised Price Target for Adamis Pharmaceuticals Corp

Adamis Stock Can Reach $13 as Symjepi Deal Is Imminent

Read more

Alibaba Group Holding Ltd (BABA) Fundamentals Remain Impressive: Mark Mahaney

Mark Mahaney of RBC Capital rates stocks in the internet sector and is one of the …

Read more